CD4 and inflammatory bowel disease: Evidence arising from experimental models of inflammatory bowel disease suggests that CD4+ T cells are key players in the initiation and regulation of the immunopathologic processes, partly through production of proinflammatory cytokines such as tumor necrosis factor-α (TNF-α) (Wells, 2011).